Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms
Open Access
- 27 April 2024
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (10) , 3291-3304
Abstract
Psilocybin has shown promise for alleviating symptoms of depression and is currently in clinical trials for the treatment of anorexia nervosa (AN), a condition that is characterised by persistent cognitive inflexibility. Considering that enhanced cognitive flexibility after psilocybin treatment is reported to occur in individuals with depression, it is plausible that psilocybin could improve symptoms of AN by breaking down cognitive inflexibility. A mechanistic understanding of the actions of psilocybin is required to tailor the clinical application of psilocybin to individuals most likely to respond with positive outcomes. This can only be achieved using incisive neurobiological approaches in animal models. Here, we use the activity-based anorexia (ABA) rat model and comprehensively assess aspects of reinforcement learning to show that psilocybin (post-acutely) improves body weight maintenance in female rats and facilitates cognitive flexibility, specifically via improved adaptation to the initial reversal of reward contingencies. Further, we reveal the involvement of signalling through the serotonin (5-HT) 1 A and 5-HT2A receptor subtypes in specific aspects of learning, demonstrating that 5-HT1A antagonism negates the cognitive enhancing effects of psilocybin. Moreover, we show that psilocybin elicits a transient increase and decrease in cortical transcription of these receptors (Htr2a and Htr1a, respectively), and a further reduction in the abundance of Htr2a transcripts in rats exposed to the ABA model. Together, these findings support the hypothesis that psilocybin could ameliorate cognitive inflexibility in the context of AN and highlight a need to better understand the therapeutic mechanisms independent of 5-HT2A receptor binding.Keywords
Funding Information
- Department of Health | National Health and Medical Research Council (GNT2011334)
This publication has 101 references indexed in Scilit:
- In pursuit of biomarkers for predicting susceptibility to activity‐based anorexia in adolescent female ratsInternational Journal of Eating Disorders, 2022
- Repetitive transcranial magnetic stimulation treatment in severe, enduring anorexia nervosa: An open longer‐term follow‐upEuropean Eating Disorders Review, 2020
- A systematic review of reviews of neurocognitive functioning in eating disorders: The state‐of‐the‐literature and future directionsInternational Journal of Eating Disorders, 2018
- A rat in the labyrinth of anorexia nervosa: Contributions of the activity‐based anorexia rodent model to the understanding of anorexia nervosaInternational Journal of Eating Disorders, 2013
- Mortality Rates in Patients With Anorexia Nervosa and Other Eating DisordersArchives of General Psychiatry, 2011
- Mortality and predictors of death in a cohort of patients presenting to an eating disorders serviceInternational Journal of Eating Disorders, 2009
- Altered Brain Serotonin 5-HT1A Receptor Binding After Recovery From Anorexia Nervosa Measured by Positron Emission Tomography and [Carbonyl11C]WAY-100635Archives of General Psychiatry, 2005
- Predictors of Mortality in Eating DisordersArchives of General Psychiatry, 2003
- Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brainJournal of Comparative Neurology, 2000
- Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?International Journal of Eating Disorders, 1999